CD20+ lymphocytes were assessed in a similar manner, demonstrating a significantly increased density in tumor tissue, an increased cell density of CD20+CD73+ B cells and a decreased expression of CD73 on CD20+ B-cells in tumor tissues [29,35,37,39,45,51]. The gene discussed is NT5E; the disease is neoplasm.